mn-cvx
type: CodeSystem
node role: treeRoot
id:
  v: mn-cvx
text:
  status:
    v: generated
  div:
    v: Generated Narrative: CodeSystem mn-cvx Properties This code system defines the following properties for its concepts Name Code URI Type status status http://hl7.org/fhir/concept-properties#status code Concepts This case-sensitive code system http://hl7.org/fhir/sid/cvx defines the following codes: Code Display Definition status 54 adenovirus, type 4 adenovirus vaccine, type 4, live, oral retired 55 adenovirus, type 7 adenovirus vaccine, type 7, live, oral retired 82 adenovirus, unspecified formulation adenovirus vaccine, unspecified formulation retired 24 Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis 19 BCG Bacillus Calmette-Guerin vaccine 27 botulinum antitoxin 26 cholera, unspecified formulation cholera vaccine, unspecified formulation retired 29 CMVIG cytomegalovirus immune globulin, intravenous 56 dengue fever tetravalent dengue fever vaccine, tetravalent 12 diphtheria antitoxin 28 DT (pediatric) diphtheria and tetanus toxoids, adsorbed for pediatric use retired 20 DTaP diphtheria, tetanus toxoids and acellular pertussis vaccine 106 DTaP, 5 pertussis antigens diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens 107 DTaP, unspecified formulation diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation retired 110 DTaP-Hep B-IPV DTaP-hepatitis B and poliovirus vaccine 50 DTaP-Hib DTaP-Haemophilus influenzae type b conjugate vaccine retired 120 DTaP-Hib-IPV diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) 130 DTaP-IPV Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated 01 DTP diphtheria, tetanus toxoids and pertussis vaccine retired 22 DTP-Hib DTP-Haemophilus influenzae type b conjugate vaccine retired 102 DTP-Hib-Hep B DTP- Haemophilus influenzae type b conjugate and hepatitis b…
url:
  v: http://hl7.org/fhir/sid/cvx
  l: cvx
version:
  v: 0.1.0
name:
  v: CVXCodeSystem
title:
  v: CDC CVX Vaccine Codes
status:
  v: active
experimental:
  v: false
date:
  v: 2026-09-08T10:09:36+08:00
publisher:
  v: Эрүүл мэндийн хөгжлийн төв (Health Development Center, Mongolia)
contact:
  name:
    v: Эрүүл мэндийн хөгжлийн төв (Health Development Center, Mongolia)
  telecom:
    system:
      v: url
    value:
      v: https://hdc.gov.mn
contact:
  name:
    v: Эрүүл мэндийн хөгжлийн төв (Health Development Center)
  telecom:
    system:
      v: url
    value:
      v: https://hdc.gov.mn
description:
  v: CDC CVX кодын жагсаалт. Дархлаажуулалтын вакциныг кодлоход ашиглана. Эх сурвалж: CDC (https://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx)
jurisdiction:
  coding:
    system:
      v: urn:iso:std:iso:3166
      l: 3166
    code:
      v: MN
case sensitive:
  v: true
content:
  v: complete
count:
  v: 289
property:
  code:
    v: status
  uri:
    v: http://hl7.org/fhir/concept-properties#status
    l: status
  type:
    v: code
concept:
  code:
    v: 54
  display:
    v: adenovirus, type 4
  definition:
    v: adenovirus vaccine, type 4, live, oral
  property:
    code:
      v: status
    value: Code
      v: retired
concept:
  code:
    v: 55
  display:
    v: adenovirus, type 7
  definition:
    v: adenovirus vaccine, type 7, live, oral
  property:
    code:
      v: status
    value: Code
      v: retired
concept:
  code:
    v: 82
  display:
    v: adenovirus, unspecified formulation
  definition:
    v: adenovirus vaccine, unspecified formulation
  property:
    code:
      v: status
    value: Code
      v: retired
concept:
  code:
    v: 24
  display:
    v: Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis
  definition:
    v: Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis
concept:
  code:
    v: 19
  display:
    v: BCG
  definition:
    v: Bacillus Calmette-Guerin vaccine
concept:
  code:
    v: 27
  display:
    v: botulinum antitoxin
concept:
  code:
    v: 26
  display:
    v: cholera, unspecified formulation
  definition:
    v: cholera vaccine, unspecified formulation
  property:
    code:
      v: status
    value: Code
      v: retired
concept:
  code:
    v: 29
  display:
    v: CMVIG
  definition:
    v: cytomegalovirus immune globulin, intravenous
concept:
  code:
    v: 56
  display:
    v: dengue fever tetravalent
  definition:
    v: dengue fever vaccine, tetravalent
concept:
  code:
    v: 12
  display:
    v: diphtheria antitoxin
concept:
  code:
    v: 28
  display:
    v: DT (pediatric)
  definition:
    v: diphtheria and tetanus toxoids, adsorbed for pediatric use
  property:
    code:
      v: status
    value: Code
      v: retired
concept:
  code:
    v: 20
  display:
    v: DTaP
  definition:
    v: diphtheria, tetanus toxoids and acellular pertussis vaccine
concept:
  code:
    v: 106
  display:
    v: DTaP, 5 pertussis antigens
  definition:
    v: diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens
concept:
  code:
    v: 107
  display:
    v: DTaP, unspecified formulation
  definition:
    v: diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation
  property:
    code:
      v: status
    value: Code
      v: retired
concept:
  code:
    v: 110
  display:
    v: DTaP-Hep B-IPV
  definition:
    v: DTaP-hepatitis B and poliovirus vaccine
concept:
  code:
    v: 50
  display:
    v: DTaP-Hib

v: DTaP-Haemophilus influenzae type b conjugate vaccine

code:
  v: status
value: Code
  v: retired

code:
  v: 120
display:
  v: DTaP-Hib-IPV
definition:
  v: diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)

code:
  v: 130
display:
  v: DTaP-IPV
definition:
  v: Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated

code:
  v: 01
display:
  v: DTP
definition:
  v: diphtheria, tetanus toxoids and pertussis vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 22
display:
  v: DTP-Hib
definition:
  v: DTP-Haemophilus influenzae type b conjugate vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 102
display:
  v: DTP-Hib-Hep B
definition:
  v: DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine

code:
  v: 57
display:
  v: hantavirus
definition:
  v: hantavirus vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 52
display:
  v: Hep A, adult
definition:
  v: hepatitis A vaccine, adult dosage

code:
  v: 83
display:
  v: Hep A, ped/adol, 2 dose
definition:
  v: hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule

code:
  v: 84
display:
  v: Hep A, ped/adol, 3 dose
definition:
  v: hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 31
display:
  v: Hep A, pediatric, unspecified formulation
definition:
  v: hepatitis A vaccine, pediatric dosage, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 85
display:
  v: Hep A, unspecified formulation
definition:
  v: hepatitis A vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 104
display:
  v: Hep A-Hep B
definition:
  v: hepatitis A and hepatitis B vaccine

code:
  v: 30
display:
  v: HBIG
definition:
  v: hepatitis B immune globulin

code:
  v: 08
display:
  v: Hep B, adolescent or pediatric
definition:
  v: hepatitis B vaccine, pediatric or pediatric/adolescent dosage

code:
  v: 42
display:
  v: Hep B, adolescent/high risk infant
definition:
  v: hepatitis B vaccine, adolescent/high risk infant dosage
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 43
display:
  v: Hep B, adult
definition:
  v: hepatitis B vaccine, adult dosage

code:
  v: 44
display:
  v: Hep B, high-dosage, dialysis or IC
definition:
  v: Hepatitis B vaccine (Hep B), high-dosage, dialysis or immunocompromised patient

code:
  v: 45
display:
  v: Hep B, unspecified formulation
definition:
  v: hepatitis B vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 58
display:
  v: Hep C
definition:
  v: hepatitis C vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 59
display:
  v: Hep E
definition:
  v: hepatitis E vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 60
display:
  v: herpes simplex 2
definition:
  v: herpes simplex virus, type 2 vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 46
display:
  v: Hib (PRP-D)
definition:
  v: Haemophilus influenzae type b vaccine, PRP-D conjugate
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 47
display:
  v: Hib (HbOC)
definition:
  v: Haemophilus influenzae type b vaccine, HbOC conjugate
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 48
display:
  v: Hib (PRP-T)
definition:
  v: Haemophilus influenzae type b vaccine, PRP-T conjugate

code:
  v: 49
display:
  v: Hib (PRP-OMP)
definition:
  v: Haemophilus influenzae type b vaccine, PRP-OMP conjugate

code:
  v: 17
display:
  v: Hib, unspecified formulation
definition:
  v: Haemophilus influenzae type b vaccine, conjugate unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 51
display:
  v: Hib-Hep B
definition:
  v: Haemophilus influenzae type b conjugate and Hepatitis B vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 61
display:
  v: HIV
definition:
  v: human immunodeficiency virus vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 118
display:
  v: HPV, bivalent
definition:
  v: human papilloma virus vaccine, bivalent
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 62
display:
  v: HPV, quadrivalent
definition:
  v: human papilloma virus vaccine, quadrivalent

code:
  v: 86
display:
  v: IG
definition:
  v: immune globulin, intramuscular

code:
  v: 87
display:
  v: IGIV
definition:
  v: immune globulin, intravenous

code:
  v: 14
display:
  v: IG, unspecified formulation
definition:
  v: immune globulin, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 111
display:
  v: Influenza, live, trivalent, intranasal, PF
definition:
  v: Influenza, live, trivalent, intranasal, preservative free

code:
  v: 15
display:
  v: influenza, split (incl. purified surface antigen)
definition:
  v: influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 16
display:
  v: influenza, whole
definition:
  v: influenza virus vaccine, whole virus
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 88
display:
  v: influenza, unspecified formulation
definition:
  v: influenza virus vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 123
display:
  v: influenza, H5N1-1203
definition:
  v: influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 10
display:
  v: IPV
definition:
  v: poliovirus vaccine, inactivated

code:
  v: 02
display:
  v: OPV, trivalent
definition:
  v: trivalent poliovirus vaccine, live, oral
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 89
display:
  v: polio, unspecified formulation
definition:
  v: poliovirus vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 39
display:
  v: Japanese encephalitis SC
definition:
  v: Japanese Encephalitis Vaccine SC
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 63
display:
  v: Junin virus
definition:
  v: Junin virus vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 64
display:
  v: leishmaniasis
definition:
  v: leishmaniasis vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 65
display:
  v: leprosy
definition:
  v: leprosy vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 66
display:
  v: Lyme disease
definition:
  v: Lyme disease vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 03
display:
  v: MMR
definition:
  v: measles, mumps and rubella virus vaccine

code:
  v: 04
display:
  v: M/R
definition:
  v: measles and rubella virus vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 94
display:
  v: MMRV
definition:
  v: measles, mumps, rubella, and varicella virus vaccine

code:
  v: 67
display:
  v: malaria
definition:
  v: malaria vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 05
display:
  v: measles
definition:
  v: measles virus vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 68
display:
  v: melanoma
definition:
  v: melanoma vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 32
display:
  v: meningococcal MPSV4
definition:
  v: meningococcal polysaccharide vaccine (MPSV4)
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 103
display:
  v: meningococcal C conjugate
definition:
  v: meningococcal C conjugate vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 114
display:
  v: meningococcal MCV4P
definition:
  v: meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)

code:
  v: 108
display:
  v: meningococcal ACWY, unspecified formulation
definition:
  v: meningococcal ACWY vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 07
display:
  v: mumps
definition:
  v: mumps virus vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 69
display:
  v: parainfluenza-3
definition:
  v: parainfluenza-3 virus vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 11
display:
  v: pertussis
definition:
  v: pertussis vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 23
display:
  v: plague
definition:
  v: plague vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 33
display:
  v: pneumococcal polysaccharide PPV23
definition:
  v: pneumococcal polysaccharide vaccine, 23 valent

code:
  v: 100
display:
  v: pneumococcal conjugate PCV 7
definition:
  v: pneumococcal conjugate vaccine, 7 valent
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 109
display:
  v: pneumococcal, unspecified formulation
definition:
  v: pneumococcal vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 70
display:
  v: Q fever
definition:
  v: Q fever vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 18
display:
  v: rabies, intramuscular injection
definition:
  v: rabies vaccine, for intramuscular injection RETIRED CODE
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 40
display:
  v: rabies, intradermal injection
definition:
  v: rabies vaccine, for intradermal injection
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 90
display:
  v: rabies, unspecified formulation
definition:
  v: rabies vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 72
display:
  v: rheumatic fever
definition:
  v: rheumatic fever vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 73
display:
  v: Rift Valley fever
definition:
  v: Rift Valley fever vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 34
display:
  v: RIG
definition:
  v: rabies immune globulin

code:
  v: 119
display:
  v: rotavirus, monovalent
definition:
  v: rotavirus, live, monovalent vaccine

code:
  v: 122
display:
  v: rotavirus, unspecified formulation
definition:
  v: rotavirus vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 116
display:
  v: rotavirus, pentavalent
definition:
  v: rotavirus, live, pentavalent vaccine

code:
  v: 74
display:
  v: rotavirus, tetravalent
definition:
  v: rotavirus, live, tetravalent vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 71
display:
  v: RSV-IGIV
definition:
  v: respiratory syncytial virus immune globulin, intravenous
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 93
display:
  v: RSV-MAb
definition:
  v: respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular

code:
  v: 06
display:
  v: rubella
definition:
  v: rubella virus vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 38
display:
  v: rubella/mumps
definition:
  v: rubella and mumps virus vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 76
display:
  v: Staphylococcus bacterio lysate
definition:
  v: Staphylococcus bacteriophage lysate
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 113
display:
  v: Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
definition:
  v: tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)

code:
  v: 09
display:
  v: Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
definition:
  v: tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)

code:
  v: 115
display:
  v: Tdap
definition:
  v: tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed

code:
  v: 35
display:
  v: tetanus toxoid, adsorbed
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 112
display:
  v: tetanus toxoid, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 77
display:
  v: Tick-borne encephalitis vaccine (non-US)

code:
  v: 13
display:
  v: TIG
definition:
  v: tetanus immune globulin

code:
  v: 95
display:
  v: TST-OT tine test
definition:
  v: tuberculin skin test; old tuberculin, multipuncture device
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 96
display:
  v: TST-PPD intradermal
definition:
  v: tuberculin skin test; purified protein derivative solution, intradermal
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 97
display:
  v: TST-PPD tine test
definition:
  v: tuberculin skin test; purified protein derivative, multipuncture device
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 98
display:
  v: TST, unspecified formulation
definition:
  v: tuberculin skin test; unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 78
display:
  v: tularemia vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 91
display:
  v: typhoid, unspecified formulation
definition:
  v: typhoid vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 25
display:
  v: typhoid, oral
definition:
  v: typhoid vaccine, live, oral

code:
  v: 41
display:
  v: typhoid, parenteral
definition:
  v: typhoid vaccine, parenteral, other than acetone-killed, dried
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 53
display:
  v: typhoid, parenteral, AKD (U.S. military)
definition:
  v: typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 101
display:
  v: typhoid, ViCPs
definition:
  v: typhoid Vi capsular polysaccharide vaccine

code:
  v: 75
display:
  v: Vaccinia (smallpox, monkeypox), live
definition:
  v: Vaccinia (smallpox, monkeypox) vaccine, live

code:
  v: 105
display:
  v: vaccinia (smallpox) diluted
definition:
  v: vaccinia (smallpox) vaccine, diluted
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 79
display:
  v: vaccinia immune globulin

code:
  v: 21
display:
  v: varicella
definition:
  v: varicella virus vaccine

code:
  v: 81
display:
  v: VEE, inactivated
definition:
  v: Venezuelan equine encephalitis, inactivated
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 80
display:
  v: VEE, live
definition:
  v: Venezuelan equine encephalitis, live, attenuated
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 92
display:
  v: VEE, unspecified formulation
definition:
  v: Venezuelan equine encephalitis vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 36
display:
  v: VZIG
definition:
  v: varicella zoster immune globulin

code:
  v: 117
display:
  v: VZIG (IND)
definition:
  v: varicella zoster immune globulin (Investigational New Drug)
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 37
display:
  v: yellow fever live
definition:
  v: yellow fever vaccine live

code:
  v: 121
display:
  v: zoster live
definition:
  v: zoster vaccine, live
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 998
display:
  v: no vaccine administered
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 999
display:
  v: unknown
definition:
  v: unknown vaccine or immune globulin
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 99
display:
  v: RESERVED - do not use
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 133
display:
  v: Pneumococcal conjugate PCV 13
definition:
  v: pneumococcal conjugate vaccine, 13 valent

code:
  v: 134
display:
  v: Japanese Encephalitis IM
definition:
  v: Japanese Encephalitis vaccine for intramuscular administration

code:
  v: 137
display:
  v: HPV, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 136
display:
  v: Meningococcal MCV4O
definition:
  v: meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)

code:
  v: 135
display:
  v: Influenza, high-dose, trivalent, PF
definition:
  v: Influenza, high-dose, split virus, trivalent, injectable, preservative free

code:
  v: 131
display:
  v: typhus, historical
definition:
  v: Historical record of a typhus vaccination
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 132
display:
  v: DTaP-IPV-HIB-HEP B, historical
definition:
  v: Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 128
display:
  v: Novel Influenza-H1N1-09, all formulations
definition:
  v: Novel influenza-H1N1-09, all formulations
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 125
display:
  v: Novel Influenza-H1N1-09, nasal
definition:
  v: Novel Influenza-H1N1-09, live virus for nasal administration
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 126
display:
  v: Novel influenza-H1N1-09, preservative-free
definition:
  v: Novel influenza-H1N1-09, preservative-free, injectable
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 127
display:
  v: Novel influenza-H1N1-09
definition:
  v: Novel influenza-H1N1-09, injectable
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 138
display:
  v: Td (adult)
definition:
  v: tetanus and diphtheria toxoids, not adsorbed, for adult use
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 139
display:
  v: Td(adult) unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 140
display:
  v: Influenza, split virus, trivalent, PF
definition:
  v: Influenza, split virus, trivalent, injectable, preservative free

code:
  v: 129
display:
  v: Japanese Encephalitis, unspecified formulation
definition:
  v: Japanese Encephalitis vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 141
display:
  v: Influenza, split virus, trivalent, preservative
definition:
  v: Influenza, split virus, trivalent, injectable, contains preservative

code:
  v: 142
display:
  v: tetanus toxoid, not adsorbed
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 143
display:
  v: Adenovirus types 4 and 7
definition:
  v: Adenovirus, type 4 and type 7, live, oral

code:
  v: 144
display:
  v: influenza, seasonal, intradermal, preservative free
definition:
  v: seasonal influenza, intradermal, preservative free
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 145
display:
  v: RSV-MAb (new)
definition:
  v: respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 146
display:
  v: DTaP,IPV,Hib,HepB
definition:
  v: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.

code:
  v: 147
display:
  v: meningococcal MCV4, unspecified formulation
definition:
  v: Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 148
display:
  v: Meningococcal C/Y-HIB PRP
definition:
  v: Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 149
display:
  v: Influenza, live, quadrivalent, intranasal

code:
  v: 150
display:
  v: Influenza, split virus, quadrivalent, PF
definition:
  v: Influenza, split virus, quadrivalent, injectable, preservative free

code:
  v: 151
display:
  v: influenza nasal, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 152
display:
  v: Pneumococcal Conjugate, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 153
display:
  v: Influenza, MDCK, trivalent, PF
definition:
  v: Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, preservative free

code:
  v: 154
display:
  v: Hep A, IG
definition:
  v: Hepatitis A immune globulin
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 155
display:
  v: Influenza, recombinant, trivalent, PF
definition:
  v: Influenza, recombinant, trivalent, injectable, preservative free

code:
  v: 156
display:
  v: Rho(D)-IG
definition:
  v: Rho(D) Immune globulin- IV or IM

code:
  v: 157
display:
  v: Rho(D) -IG IM
definition:
  v: Rho(D) Immune globulin - IM

code:
  v: 158
display:
  v: Influenza, split virus, quadrivalent, preservative
definition:
  v: Influenza, split virus, quadrivalent, injectable, contains preservative

code:
  v: 159
display:
  v: Rho(D) - Unspecified formulation
definition:
  v: Rho(D) Unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 160
display:
  v: Influenza A monovalent (H5N1), ADJUVANTED-2013
definition:
  v: Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013

code:
  v: 801
display:
  v: AS03 Adjuvant

code:
  v: 161
display:
  v: Influenza, injectable,quadrivalent, preservative free, pediatric

code:
  v: 162
display:
  v: meningococcal B, recombinant
definition:
  v: meningococcal B vaccine, fully recombinant

code:
  v: 163
display:
  v: meningococcal B, OMV
definition:
  v: meningococcal B vaccine, recombinant, OMV, adjuvanted

code:
  v: 164
display:
  v: meningococcal B, unspecified
definition:
  v: meningococcal B, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 165
display:
  v: HPV9
definition:
  v: Human Papillomavirus 9-valent vaccine

code:
  v: 166
display:
  v: influenza, intradermal, quadrivalent, preservative free
definition:
  v: influenza, intradermal, quadrivalent, preservative free, injectable
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 167
display:
  v: meningococcal, unknown serogroups
definition:
  v: meningococcal vaccine of unknown formulation and unknown serogroups
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 168
display:
  v: Influenza, adjuvanted, trivalent, PF
definition:
  v: Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free

code:
  v: 169
display:
  v: Hep A, live attenuated
definition:
  v: Hep A, live attenuated-IM

code:
  v: 170
display:
  v: DTAP/IPV/HIB - non-US
definition:
  v: non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)

code:
  v: 171
display:
  v: Influenza, MDCK, quadrivalent, PF
definition:
  v: Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, preservative free

code:
  v: 172
display:
  v: cholera, WC-rBS

code:
  v: 173
display:
  v: cholera, BivWC

code:
  v: 174
display:
  v: cholera, live attenuated

code:
  v: 175
display:
  v: Rabies - IM Diploid cell culture
definition:
  v: Human Rabies vaccine from human diploid cell culture

code:
  v: 176
display:
  v: Rabies - IM fibroblast culture
definition:
  v: Human rabies vaccine from Chicken fibroblast culture

code:
  v: 177
display:
  v: PCV10
definition:
  v: pneumococcal conjugate vaccine, 10 valent

code:
  v: 178
display:
  v: OPV bivalent
definition:
  v: Non-US bivalent oral polio vaccine (types 1 and 3)

code:
  v: 179
display:
  v: OPV ,monovalent, unspecified
definition:
  v: Non-US monovalent oral polio vaccine, unspecified formulation

code:
  v: 180
display:
  v: tetanus immune globulin
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 181
display:
  v: anthrax immune globulin

code:
  v: 182
display:
  v: OPV, Unspecified
definition:
  v: Oral Polio Vaccine, Unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 183
display:
  v: Yellow fever vaccine live - alt
definition:
  v: Yellow fever vaccine live - alternative formulation for vaccine shortage

code:
  v: 184
display:
  v: Yellow fever, unspecified
definition:
  v: Yellow fever vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 185
display:
  v: Influenza, recombinant, quadrivalent, PF
definition:
  v: Influenza, recombinant, quadrivalent, injectable, preservative free

code:
  v: 186
display:
  v: Influenza, MDCK, quadrivalent, preservative
definition:
  v: Influenza, Madin Darby Canine Kidney, subunit, quadrivalent, injectable, contains preservative

code:
  v: 187
display:
  v: zoster recombinant
definition:
  v: zoster vaccine recombinant

code:
  v: 188
display:
  v: zoster, unspecified formulation
definition:
  v: zoster vaccine, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 189
display:
  v: HepB-CpG
definition:
  v: Hepatitis B vaccine (recombinant), CpG adjuvanted

code:
  v: 190
display:
  v: Typhoid conjugate vaccine (TCV)
definition:
  v: Typhoid conjugate vaccine (non-US)

code:
  v: 191
display:
  v: meningococcal A polysaccharide (non-US)
definition:
  v: meningococcal A polysaccharide vaccine (non-US)

code:
  v: 192
display:
  v: meningococcal AC polysaccharide (non-US)
definition:
  v: meningococcal AC polysaccharide vaccine (non-US)

code:
  v: 193
display:
  v: Hep A-Hep B, pediatric/adolescent
definition:
  v: hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)

code:
  v: 194
display:
  v: Influenza, Southern Hemisphere
definition:
  v: influenza, Southern Hemisphere, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 195
display:
  v: DT, IPV adsorbed
definition:
  v: Diphtheria, Tetanus, Poliomyelitis adsorbed

code:
  v: 196
display:
  v: Td, adsorbed, preservative free, adult use, Lf unspecified
definition:
  v: tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified

code:
  v: 197
display:
  v: Influenza, high-dose, quadrivalent, PF
definition:
  v: Influenza, high-dose, split virus, quadrivalent, injectable, preservative free

code:
  v: 200
display:
  v: influenza, Southern Hemisphere, pediatric, preservative free
definition:
  v: influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free

code:
  v: 201
display:
  v: Influenza, Southern Hemisphere, quadrivalent, PF
definition:
  v: Influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5 mL dose, preservative free

code:
  v: 202
display:
  v: influenza, Southern Hemisphere, quadrivalent, with preservative
definition:
  v: influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative

code:
  v: 198
display:
  v: DTP-hepB-Hib Pentavalent Non-US
definition:
  v: Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)

code:
  v: 203
display:
  v: meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)
definition:
  v: meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free

code:
  v: 205
display:
  v: Influenza, adjuvanted, quadrivalent, PF
definition:
  v: Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free

code:
  v: 206
display:
  v: Vaccinia, smallpox monkeypox vaccine live, PF, SQ or ID injection
definition:
  v: Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection

code:
  v: 207
display:
  v: COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 208
display:
  v: COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 213
display:
  v: SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 210
display:
  v: COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL

code:
  v: 212
display:
  v: COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 204
display:
  v: Ebola Zaire vaccine, live, recombinant, 1mL dose

code:
  v: 214
display:
  v: Ebola, unspecified
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 211
display:
  v: COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 500
display:
  v: COVID-19 Non-US Vaccine, UNSPECIFIED
definition:
  v: SARS-COV-2 (COVID-19) Non-US Vaccine, UNSPECIFIED

code:
  v: 501
display:
  v: COVID-19 IV Non-US Vaccine (QAZCOVID-IN)
definition:
  v: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)

code:
  v: 502
display:
  v: COVID-19 IV Non-US Vaccine (COVAXIN)
definition:
  v: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)

code:
  v: 503
display:
  v: COVID-19 LAV Non-US Vaccine (COVIVAC)
definition:
  v: SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)

code:
  v: 504
display:
  v: COVID-19 VVnr Non-US Vaccine (Sputnik Light)
definition:
  v: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)

code:
  v: 505
display:
  v: COVID-19 VVnr Non-US Vaccine (Sputnik V)
definition:
  v: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)

code:
  v: 506
display:
  v: COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology
definition:
  v: SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology

code:
  v: 507
display:
  v: COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)
definition:
  v: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)

code:
  v: 508
display:
  v: COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)
definition:
  v: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)

code:
  v: 509
display:
  v: COVID-19 PS Non-US Vaccine (EpiVacCorona)
definition:
  v: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)

code:
  v: 510
display:
  v: COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)
definition:
  v: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)

code:
  v: 511
display:
  v: COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)
definition:
  v: SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)

code:
  v: 215
display:
  v: Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF
definition:
  v: Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free

code:
  v: 216
display:
  v: Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF
definition:
  v: Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free

code:
  v: 219
display:
  v: COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 217
display:
  v: COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 218
display:
  v: COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 220
display:
  v: HepB recombinant, 3-antigen, Al(OH)3
definition:
  v: Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 221
display:
  v: COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 222
display:
  v: Tick-borne encephalitis, unspecified
definition:
  v: Tick-borne encephalitis vaccine, unspecified
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 223
display:
  v: Tick-borne encephalitis, inactivated, PF, 0.25mL
definition:
  v: Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose

code:
  v: 224
display:
  v: Tick-borne encephalitis, inactivated, PF, 0.5mL
definition:
  v: Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose

code:
  v: 225
display:
  v: COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 226
display:
  v: COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 512
display:
  v: SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)
definition:
  v: SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)

code:
  v: 513
display:
  v: SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)
definition:
  v: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)

code:
  v: 514
display:
  v: SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)
definition:
  v: SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)

code:
  v: 515
display:
  v: SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)
definition:
  v: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)

code:
  v: 516
display:
  v: COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)
definition:
  v: SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)

code:
  v: 517
display:
  v: SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)
definition:
  v: SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)

code:
  v: 227
display:
  v: COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 228
display:
  v: COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 229
display:
  v: COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 301
display:
  v: COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 300
display:
  v: COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 230
display:
  v: COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 518
display:
  v: COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)
definition:
  v: SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)

code:
  v: 519
display:
  v: COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna
definition:
  v: SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna

code:
  v: 520
display:
  v: COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech
definition:
  v: SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech

code:
  v: 521
display:
  v: COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK
definition:
  v: SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK

code:
  v: 231
display:
  v: influenza, Southern Hemisphere, high-dose, quadrivalent
definition:
  v: influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free

code:
  v: 303
display:
  v: RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF
definition:
  v: Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free

code:
  v: 304
display:
  v: Respiratory syncytial virus (RSV), unspecified
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 305
display:
  v: RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF
definition:
  v: Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free

code:
  v: 306
display:
  v: RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months
definition:
  v: Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months

code:
  v: 307
display:
  v: RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months
definition:
  v: Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months

code:
  v: 313
display:
  v: COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose

code:
  v: 308
display:
  v: COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 309
display:
  v: COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose

code:
  v: 310
display:
  v: COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose

code:
  v: 312
display:
  v: COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose

code:
  v: 311
display:
  v: COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose

code:
  v: 315
display:
  v: Respiratory syncytial virus (RSV) MAB, unspecified
definition:
  v: Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 314
display:
  v: Respiratory syncytial virus (RSV) vaccine, unspecified
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 316
display:
  v: Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF
definition:
  v: Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free

code:
  v: 317
display:
  v: Chikungunya live attenuated vaccine, 0.5 mL, PF
definition:
  v: Chikungunya, live attenuated vaccine, 0.5 mL, preservative free

code:
  v: 318
display:
  v: Anthrax, post-exposure prophylaxis
definition:
  v: Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis

code:
  v: 319
display:
  v: Anthrax vaccine, unspecified
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 320
display:
  v: Influenza, MDCK, trivalent, preservative
definition:
  v: Influenza, Madin Darby Canine Kidney, subunit, trivalent, injectable, contains preservative

code:
  v: 321
display:
  v: Influenza-avian, H5N8, monovalent, PF
definition:
  v: Influenza-avian, H5N8, viral-vector, monovalent, injectable, preservative free

code:
  v: 322
display:
  v: Influenza-avian, H5N8, monovalent, preservative
definition:
  v: Influenza-avian, H5N8, viral-vector, monovalent, injectable, contains preservative

code:
  v: 324
display:
  v: Poliovirus, inactivated, fractional-dose (fIPV)

code:
  v: 323
display:
  v: Influenza-avian, H5, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 326
display:
  v: RSV, mRNA, injectable, PF
definition:
  v: Respiratory syncytial virus (RSV), mRNA, injectable, preservative free

code:
  v: 327
display:
  v: Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF
definition:
  v: Pneumococcal conjugate vaccine, 21 valent (PCV21), polysaccharide CRM197 conjugate, preservative free

code:
  v: 328
display:
  v: Meningococcal oligosaccharide (MenACWY), (MenB), PF
definition:
  v: Meningococcal oligosaccharide conjugated (groups A, C, W, Y) and group B, 0.5 mL, preservative free

code:
  v: 329
display:
  v: Chikungunya, VLP, recombinant, 0.8 mL, PF
definition:
  v: Chikungunya, virus-like particle (VLP), recombinant vaccine, 0.8 mL, preservative free

code:
  v: 330
display:
  v: Dengue fever, unspecified
definition:
  v: Dengue fever, unspecified formulation
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 331
display:
  v: Influenza, Southern Hemisphere, trivalent, PF
definition:
  v: Influenza, seasonal, Southern Hemisphere, trivalent, 0.5 mL dose, preservative free

code:
  v: 325
display:
  v: Vaccinia (smallpox, monkeypox), unspecified
property:
  code:
    v: status
  value: Code
    v: retired

code:
  v: 332
display:
  v: RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF
definition:
  v: Respiratory syncytial virus (RSV), monoclonal antibody, IgG1κ, (clesrovimab-cfor), 0.7 mL, neonate and infant, preservative free

code:
  v: 333
display:
  v: Influenza, live, trivalent, intranasal, self/caregiver admin, PF
definition:
  v: Influenza, live, trivalent, intranasal, self or caregiver administered, preservative free

code:
  v: 334
display:
  v: COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2 mL dose

code:
  v: 337
display:
  v: Influenza, Southern Hemisphere, high-dose, trivalent, PF
definition:
  v: Influenza, Southern Hemisphere, high-dose, split virus, trivalent, 0.5 mL, injectable, preservative free

code:
  v: 302
display:
  v: COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose
definition:
  v: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation
property:
  code:
    v: status
  value: Code
    v: retired